Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/35730
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorLOPES, Thaisa Regina Rocha
dc.contributor.authorGONCALES, Juliana Prado
dc.contributor.authorSILVA JUNIOR, Jose Valter Joaquim
dc.contributor.authorLORENA, Virginia Maria Barros de
dc.contributor.authorTOSCANO, Ana Luiza Castro Conde
dc.contributor.authorAKAMATSU, Sandra Mitie
dc.contributor.authorSALLES, Angela Christina
dc.contributor.authorTOZETTO-MENDOZA, Tania Regina
dc.contributor.authorMORAIS, Viviane Martha Santos de
dc.contributor.authorCOELHO, Maria Rosangela Cunha Duarte
dc.date.accessioned2020-03-24T15:16:55Z
dc.date.available2020-03-24T15:16:55Z
dc.date.issued2020
dc.identifier.citationHUMAN IMMUNOLOGY, v.81, n.1, p.26-31, 2020
dc.identifier.issn0198-8859
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/35730
dc.description.abstractHuman gammaherpesvirus 8 (HHV-8) is the etiologic agent of Kaposi's sarcoma (KS), one of the most common cancers in people living with HIV/AIDS. It is believe that the course of both HIV and HHV-8 infection is associated with the imbalance of anti- and/or pro-inflammatory cytokines. Here, we evaluated the IL-6, TNF-alpha, IL-10, CCL2 and CXCL10 serum concentrations in HIV- and HIV/HHV-8 (without KS) individuals, and in patients with cutaneous or visceral AIDS-KS. Serum concentrations of IL-6, IL-10 and CXCL10 were significantly higher in the AIDS-KS group compared to HIV and HIV/HHV-8 individuals. Similarly, the concentrations of theses cytokines were higher in patients with visceral than in those with cutaneous AIDS-KS. The TNF-alpha concentration was significantly higher in the HIV group compared to HIV/HHV-8 (with and without KS) individuals, and CCL2 levels did not present significant difference among the groups. The HIV viral load was undetectable in all patients from the HIV and HIV/HHV-8 groups. On the other hand, in the AIDS-KS group, most patients had detectable HIV viral load. In this context, we believe that the cytokine levels in AIDS-KS may be result of a complex interaction between HIV, HHV-8 and immunity.eng
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for Scientific and Technological Development (CNPq)
dc.description.sponsorshipCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
dc.description.sponsorshipFundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INCeng
dc.relation.ispartofHuman Immunology
dc.rightsrestrictedAccesseng
dc.subjectHIV/AIDSeng
dc.subjectHHV-8eng
dc.subjectKaposi's sarcomaeng
dc.subjectAIDS-KSeng
dc.subjectPathogenesiseng
dc.subject.otherlytic cycle replicationeng
dc.subject.otherc-reactive proteineng
dc.subject.othergrowth-factoreng
dc.subject.othergene-expressioneng
dc.subject.otherhiv-infectioneng
dc.subject.otherup-regulationeng
dc.subject.otherherpesviruseng
dc.subject.otherinterleukin-6eng
dc.subject.otherpathogenesiseng
dc.subject.otherchemokineeng
dc.titleAssociation of IL-6, IL-10 and CXCL10 serum concentrations with visceral Kaposi's sarcoma in people living with HIV/AIDSeng
dc.typearticleeng
dc.rights.holderCopyright ELSEVIER SCIENCE INCeng
dc.identifier.doi10.1016/j.humimm.2019.11.007
dc.identifier.pmid31866063
dc.subject.wosImmunologyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalLOPES, Thaisa Regina Rocha:Univ Fed Pernambuco, Virol Sect, Lab Immunopathol Keizo Asami, Recife, PE, Brazil
hcfmusp.author.externalGONCALES, Juliana Prado:Univ Fed Pernambuco, Virol Sect, Lab Immunopathol Keizo Asami, Recife, PE, Brazil
hcfmusp.author.externalSILVA JUNIOR, Jose Valter Joaquim:Univ Fed Santa Maria, Dept Prevent Vet Med, Virol Sect, Santa Maria, RS, Brazil; Univ Fed Santa Maria, Dept Microbiol & Parasitol, Santa Maria, RS, Brazil
hcfmusp.author.externalLORENA, Virginia Maria Barros de:Fundacao Oswaldo Cruz, Aggeu Magalhiies Inst, Dept Immunol, Recife, PE, Brazil
hcfmusp.author.externalTOSCANO, Ana Luiza Castro Conde:Inst Infectol Emilio Ribas, Sao Paulo, Brazil
hcfmusp.author.externalAKAMATSU, Sandra Mitie:Inst Infectol Emilio Ribas, Sao Paulo, Brazil
hcfmusp.author.externalSALLES, Angela Christina:Inst Infectol Emilio Ribas, Sao Paulo, Brazil
hcfmusp.author.externalMORAIS, Viviane Martha Santos de:Univ Fed Pernambuco, Virol Sect, Lab Immunopathol Keizo Asami, Recife, PE, Brazil
hcfmusp.author.externalCOELHO, Maria Rosangela Cunha Duarte:Univ Fed Pernambuco, Virol Sect, Lab Immunopathol Keizo Asami, Recife, PE, Brazil; Univ Fed Pernambuco, Ctr Biosci, Dept Physiol & Pharmacol, Recife, PE, Brazil
hcfmusp.description.beginpage26
hcfmusp.description.endpage31
hcfmusp.description.issue1
hcfmusp.description.volume81
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000511233700008
hcfmusp.origem.id2-s2.0-85076829675
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceBergler-Czop B, 2016, POSTEP DERM ALERGOL, V33, P149, DOI 10.5114/ada.2016.59163eng
hcfmusp.relation.referenceBolanos R., 2018, CANC RES FRONT, V4, P45eng
hcfmusp.relation.referenceBorges AH, 2016, J INFECT DIS, V214, P408, DOI 10.1093/infdis/jiw173eng
hcfmusp.relation.referenceBorges AH, 2015, J INFECT DIS, V212, P585, DOI 10.1093/infdis/jiv123eng
hcfmusp.relation.referenceBrinkmann MM, 2007, J VIROL, V81, P42, DOI 10.1128/JVI.00648-06eng
hcfmusp.relation.referenceCai J, 1997, BLOOD, V89, P1491, DOI 10.1182/blood.V89.5.1491.1491_1491_1500eng
hcfmusp.relation.referenceCouty JP, 2009, J PHARMACOL EXP THER, V329, P1142, DOI 10.1124/jpet.108.147686eng
hcfmusp.relation.referencede Medeiros RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156163eng
hcfmusp.relation.referenceDenner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055199eng
hcfmusp.relation.referenceDiMaio TA, 2014, J VIROL, V88, P14301, DOI 10.1128/JVI.01696-14eng
hcfmusp.relation.referenceEl-Mallawany NK, 2019, INT J CANCER, V144, P110, DOI 10.1002/ijc.31863eng
hcfmusp.relation.referenceEnsoli B, 2000, SEMIN CANCER BIOL, V10, P367, DOI 10.1006/scbi.2000.0329eng
hcfmusp.relation.referenceEnsoli B, 2001, EUR J CANCER, V37, P1251, DOI 10.1016/S0959-8049(01)00121-6eng
hcfmusp.relation.referenceFatahzadeh M, 2012, OR SURG OR MED OR PA, V113, P2, DOI 10.1016/j.tripleo.2011.05.011eng
hcfmusp.relation.referenceGanem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133eng
hcfmusp.relation.referenceGodinho NMO, 2008, FORENS SCI INT-GEN S, V1, P329, DOI 10.1016/j.fsigss.2007.10.069eng
hcfmusp.relation.referenceHensler HR, 2009, J GEN VIROL, V90, P79, DOI 10.1099/vir.0.006239-0eng
hcfmusp.relation.referenceHuang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902eng
hcfmusp.relation.referenceKawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267eng
hcfmusp.relation.referenceKnowlton ER, 2014, MBIO, V5, DOI 10.1128/mBio.01277-14eng
hcfmusp.relation.referenceKROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201eng
hcfmusp.relation.referenceKumar A, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/484378eng
hcfmusp.relation.referenceLidenge SJ, 2019, J INFECT DIS, V219, P1318, DOI 10.1093/infdis/jiy654eng
hcfmusp.relation.referenceMachado PRL, 2014, VIRAL IMMUNOL, V27, P356, DOI 10.1089/vim.2013.0134eng
hcfmusp.relation.referenceLins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976eng
hcfmusp.relation.referenceLo BKK, 2010, AM J PATHOL, V176, P2435, DOI 10.2353/ajpath.2010.081059eng
hcfmusp.relation.referenceMait-Kaufman J, 2015, AIDS RES HUM RETROV, V31, P615, DOI [10.1089/aid.2014.0085, 10.1089/AID.2014.0085]eng
hcfmusp.relation.referenceValverde-Villegas JM, 2018, INFECT GENET EVOL, V57, P51, DOI 10.1016/j.meegid.2017.11.002eng
hcfmusp.relation.referenceMartellotta F, 2009, CURR HIV RES, V7, P634, DOI 10.2174/157016209789973619eng
hcfmusp.relation.referenceMaurer T, 2007, NEW ENGL J MED, V357, P1352, DOI 10.1056/NEJMc070508eng
hcfmusp.relation.referenceMesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888eng
hcfmusp.relation.referenceMILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068eng
hcfmusp.relation.referenceMtonga W, 2018, CURR HIV RES, V16, P231, DOI 10.2174/1570162X16666180711103610eng
hcfmusp.relation.referenceNascimento MC, 2007, J CLIN MICROBIOL, V45, P715, DOI 10.1128/JCM.01264-06eng
hcfmusp.relation.referenceOksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073eng
hcfmusp.relation.referencePena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063eng
hcfmusp.relation.referenceProvenzano G, 2003, ANN RHEUM DIS, V62, P680, DOI 10.1136/ard.62.7.680eng
hcfmusp.relation.referenceQin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251eng
hcfmusp.relation.referenceRohner E, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.261.11300eng
hcfmusp.relation.referenceRuocco E, 2013, CLIN DERMATOL, V31, P413, DOI 10.1016/j.clindermatol.2013.01.008eng
hcfmusp.relation.referenceSCIACCA FL, 1994, J IMMUNOL, V153, P4816eng
hcfmusp.relation.referenceSimmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bceng
hcfmusp.relation.referenceTasca KI, 2012, REV SOC BRAS MED TRO, V45, P663, DOI 10.1590/S0037-86822012000600002eng
hcfmusp.relation.referenceTedeschi R, 2015, ONCOTARGET, V6, P30334, DOI 10.18632/oncotarget.4571eng
hcfmusp.relation.referenceTorre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262eng
hcfmusp.relation.referenceTso FY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006844eng
hcfmusp.relation.referenceUldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798eng
hcfmusp.relation.referenceUllum H, 1996, J ACQ IMMUN DEF SYND, V13, P93, DOI 10.1097/00042560-199609000-00013eng
hcfmusp.relation.referenceUnemori P, 2013, AIDS, V27, P1735, DOI 10.1097/QAD.0b013e3283601144eng
hcfmusp.relation.referenceVarthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434eng
hcfmusp.relation.referenceVenketaraman V, 2011, HIV AIDS UPDATES BIO, P281eng
hcfmusp.relation.referenceWang Z, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01274eng
hcfmusp.relation.referenceWeiss E, 2004, J AM ACAD DERMATOL, V50, P657, DOI 10.1016/j.jaad.2003.11.075eng
hcfmusp.relation.referenceWest J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07eng
hcfmusp.relation.referenceZeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1879-1166
hcfmusp.citation.scopus12-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - IMT
Instituto de Medicina Tropical - IMT

Artigos e Materiais de Revistas Científicas - LIM/52
LIM/52 - Laboratório de Virologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_LOPES_Association_of_IL6_IL10_and_CXCL10_serum_concentrations_2020.PDF.pdf
  Restricted Access
publishedVersion (English)605.32 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.